CD28 and cancer: Costimulatory receptor molecules that mediate the signalling transduction pathways of T-cell proliferation, differentiation and activation, such as cluster of differentiation 27 (CD27) and 28 (CD28), have been proposed as important immunomodulation targets in cancer treatments31,32.